Cannabis Strategic Ventures
On January 24, Cannabis Strategic Ventures (NUGS) stock closed at $1.69, which is an ~8.33% rise compared to its closing price of $203.66 on January 23 and a decline of ~11% YTD (year-to-date). On January 16–17, the company’s stock price grew ~28.47% and ~22.16%, respectively.
On January 23, Cannabis Strategic Ventures stock declined ~10.34% to $1.56 from $1.74 the previous day. Cannabis Strategic Ventures hit its 52-week high of $5.94 on August 24 and its 52-week low of $1.02 on April 4.
Innovative Industrial Properties
On January 24, Innovative Industrial Properties (IIPR) stock grew ~1.70% to $57.90, which is also ~28% YTD (year-to-date) growth in January. The company hit its 52-week high of $59.90. Among the three analysts tracking Innovative Industrial Properties in January 2019, all of them recommended a “strong buy.” The consensus 12-month target price was $53.17, which is an ~8.17% discount over the company’s closing price of $57.90 on January 24.
GW Pharmaceuticals’ (GWPH) stock price closed at $138.25 on January 24, which is 42% YTD growth in January and ~1.84% higher than its previous closing price of $135.75. To learn more, read Here Are Some of GW Pharmaceuticals’ Key Growth Drivers.
Cannabis industry’s performance
On January 24, the ETFMG Alternative Harvest ETF (MJ), which tracks global cannabis companies, grew ~1.83%. The Horizons Marijuana Life Sciences Index ETF (HMLSF), which tracks North American medical marijuana companies, grew ~2.14%.
HMLSF and MJ invest ~10.17% and ~5.95%, respectively, of their total portfolio holdings in GW Pharmaceuticals.